Gene-editing technique to treat lung cancer is due to be tested in people in August.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption
Nature Communications Open Access 24 September 2022
-
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Nature Communications Open Access 23 April 2019
-
Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
Scientific Reports Open Access 03 August 2018
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
First CRISPR clinical trial gets green light from US panel 2016-Jun-22
Leukaemia success heralds wave of gene-editing therapies 2015-Nov-05
Related external links
Rights and permissions
About this article
Cite this article
Cyranoski, D. Chinese scientists to pioneer first human CRISPR trial. Nature 535, 476–477 (2016). https://doi.org/10.1038/nature.2016.20302
Published:
Issue date:
DOI: https://doi.org/10.1038/nature.2016.20302
This article is cited by
-
Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption
Nature Communications (2022)
-
Recent advances in liposome formulations for breast cancer therapeutics
Cellular and Molecular Life Sciences (2021)
-
CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury
Molecular Neurobiology (2020)
-
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Nature Communications (2019)
-
Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
Scientific Reports (2018)
